Newsroom

Industry News

10 May

OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Metastatic Melanoma

SAN DIEGO, May 10, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec”) (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, has entered a clinical trial collaboration and supply agreement with Merck (known as MSD outside the United States and Canada) to evaluate the combination of OncoSec’s ImmuoPulse® IL-12 with Merck’s anti-PD-1...

Read more

10 May

Inovio Provides Update on MedImmune Launch of Combination Trial for HPV-associated Head & Neck Cancer

PLYMOUTH MEETING, Pa., May 10, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced MedImmune, AstraZeneca’s global biologics research and development arm, will start a new clinical trial investigating the combination of MEDI0457, an immunotherapy designed to generate antigen specific killer T cell responses targeting HPV-associated tumors, and...

Read more

10 May

IsoRay Announces Third Quarter Fiscal 2017 Financial Results

RICHLAND, Wash., May 10, 2017 /PRNewswire/ — IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced financial results for the third quarter of fiscal 2017, ended March...

Read more

9 May

RegeneRx JV Presents Results of Phase 2b/3 (ARISE-1) Dry Eye Trial at ARVO 2017

ROCKVILLE, Md., May 9, 2017 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced that its joint venture, ReGenTree LLC, presented the results of its ARISE-1 Phase 2b/3 dry eye clinical trial in a poster session...

Read more

9 May

Precision Optics Corporation Schedules Third Quarter Conference Call

GARDNER, Mass., May 08, 2017 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (PEYE) (the “Company”) announced that it intends to release its financial results for the fiscal 2017 third quarter ended March 31, 2017 after market trading ends on Monday, May 15, 2017. Management has scheduled a conference call...

Read more

9 May

Mateon Provides Corporate Update and Reports First Quarter 2017 Financial Results

SOUTH SAN FRANCISCO, Calif., May 08, 2017 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today provided a corporate update and reported financial results for the three months ended March 31, 2017. Recent Corporate Highlights...

Read more

9 May

Youngevity International, Inc. (YGYI) to Host First Quarter 2017 Earnings Conference Call to Review Financial Results and Provide Corporate Update

SAN DIEGO, CA–(Marketwired – May 8, 2017) – Youngevity International, Inc. ( OTCQX : YGYI ) (www.YGYI.com), a leading omni-direct lifestyle company, announced today that it will host a conference call on Friday, May 12, 2017 at 4:15 Eastern Daylight Time, (1:15 Pacific Daylight Time), to discuss the Company’s first...

Read more

Page 4 of 234« First...23456...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address